288 related articles for article (PubMed ID: 17384509)
1. Neoadjuvant radiochemotherapy for rectal cancer.
Vini L
Dig Dis; 2007; 25(1):56-66. PubMed ID: 17384509
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.
Bujko K; Nowacki MP; Nasierowska-Guttmejer A; Michalski W; Bebenek M; Kryj M
Br J Surg; 2006 Oct; 93(10):1215-23. PubMed ID: 16983741
[TBL] [Abstract][Full Text] [Related]
3. Preoperative or postoperative therapy for stage II or III rectal cancer: an updated practice guideline.
Wong RK; Berry S; Spithoff K; Simunovic M; Chan K; Agboola O; Dingle B;
Clin Oncol (R Coll Radiol); 2010 May; 22(4):265-71. PubMed ID: 20398849
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy and concurrent radiochemotherapy for rectal cancer.
Rödel C; Sauer R
Surg Oncol; 2004; 13(2-3):93-101. PubMed ID: 15572091
[TBL] [Abstract][Full Text] [Related]
5. High dose rate brachytherapy as a boost after preoperative chemoradiotherapy for more advanced rectal tumours: the Clatterbridge experience.
Sun Myint A; Lee CD; Snee AJ; Perkins K; Jelley FE; Wong H
Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):711-9. PubMed ID: 17884396
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy and local control in rectal cancer.
Valentini V; Rosetto ME; Fares C; Mantini G; Salvi G; Turriziani A
Rays; 1998; 23(3):580-5. PubMed ID: 9932477
[TBL] [Abstract][Full Text] [Related]
7. [Prevention of pelvic recurrence by preoperative radiochemotherapy and total mesorectal excision of rectal carcinoma?].
Bosset JF; Horiot JC
Praxis (Bern 1994); 2001 Apr; 90(14):581-6. PubMed ID: 11320885
[TBL] [Abstract][Full Text] [Related]
8. [Neoadjuvant chemoradiation therapy for locally advanced rectal cancer].
Sato T; Ozawa H; Kisyu K; Kumamoto H; Nakamura T; Onozato W; Yamanashi T; Kokuba Y; Ihara A; Watanabe M
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1553-6. PubMed ID: 17940371
[TBL] [Abstract][Full Text] [Related]
9. [Adjuvant and neoadjuvant radiochemotherapy of rectal carcinoma].
Sauer R; Rödel C
Praxis (Bern 1994); 2002 Sep; 91(37):1476-84. PubMed ID: 12360683
[TBL] [Abstract][Full Text] [Related]
10. [Adjuvant radiochemotherapy of rectal carcinoma].
Keilholz L; Sauer R
Praxis (Bern 1994); 1995 Nov; 84(47):1377-82. PubMed ID: 7501919
[TBL] [Abstract][Full Text] [Related]
11. cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted.
Guillem JG; Díaz-González JA; Minsky BD; Valentini V; Jeong SY; Rodriguez-Bigas MA; Coco C; Leon R; Hernandez-Lizoain JL; Aristu JJ; Riedel ER; Nitti D; Wong WD; Pucciarelli S
J Clin Oncol; 2008 Jan; 26(3):368-73. PubMed ID: 18202411
[TBL] [Abstract][Full Text] [Related]
12. The role of neoadjuvant therapy in sphincter-saving surgery for mid and distal rectal cancer.
Leibold T; Guillem JG
Cancer Invest; 2010 Mar; 28(3):259-67. PubMed ID: 19857039
[TBL] [Abstract][Full Text] [Related]
13. The role of preoperative and postoperative radiotherapy in rectal cancer.
Glimelius BL
Clin Colorectal Cancer; 2002 Aug; 2(2):82-92. PubMed ID: 12453322
[TBL] [Abstract][Full Text] [Related]
14. Point: short-course radiation therapy is preferable in the neoadjuvant treatment of rectal cancer.
Bujko K; Bujko M
Semin Radiat Oncol; 2011 Jul; 21(3):220-7. PubMed ID: 21645867
[TBL] [Abstract][Full Text] [Related]
15. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
[TBL] [Abstract][Full Text] [Related]
16. [Rectal carcinoma: is too much neoadjuvant therapy performed? Proposals for a more selective MRI based indication].
Junginger T; Hermanek P; Oberholzer K; Schmidberger H
Zentralbl Chir; 2006 Aug; 131(4):275-84. PubMed ID: 17004186
[TBL] [Abstract][Full Text] [Related]
17. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
[TBL] [Abstract][Full Text] [Related]
18. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.
Valentini V; Coco C; Minsky BD; Gambacorta MA; Cosimelli M; Bellavita R; Morganti AG; La Torre G; Trodella L; Genovesi D; Portaluri M; Maurizi-Enrici R; Barbera F; Maranzano E; Lupattelli M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):403-12. PubMed ID: 17919844
[TBL] [Abstract][Full Text] [Related]
19. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
20. Developments in the use of chemoradiotherapy in rectal cancer.
Sebag-Montefiore D
Colorectal Dis; 2006 Sep; 8 Suppl 3():14-7. PubMed ID: 16813586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
